Perbedaan Kawasan Industri Jababeka Tbk. dan Organon Pharma Indonesia Tbk.: Kawasan Industri Jababeka Tbk. diperdagangkan di Rp197 (kapitalisasi pasar 3,96 T, volume 24 jam 426,54 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Kawasan Industri Jababeka Tbk. jauh lebih besar — sekitar 37,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| KIJA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 3,96 T | 104,4 M |
Volume | 426,54 jt | — |
Lot | 4,27 jt | — |
Perputaran | 83,21 M | — |
Harga Rata-rata | 195,09 | — |
Nilai Transaksi | 83,21 M | — |
Harga Ekuilibrium Indikatif | 197 | — |
Volume Ekuilibrium Indikatif | 118,64 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Kawasan Industri Jababeka Tbk (the Company) was established within the framework of the Domestic Capital Investment Law No.6 year 1968 which was amended by Law No.12 year 1970, based on notarial deed No.18 of Maria Kristiana Soeharyo, S.H., dated January 12, 1989. The Company started its commercial operations in 1990. The Companys shares are listed on JSX and SSX.
Selengkapnya di halaman KIJA →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →